Amman: Jordan Food and Drug Administration (JFDA) underlined the importance of administering intravenous iron infusions under medical supervision to ensure "correct" dosage and prevent potential health complications, primarily allergic reactions that may require emergency procedures due to the rare but serious risk to life. In a statement issued Sunday, the JFDA detailed that allergic reactions can surface as mild symptoms, mainly skin rash, itching, redness, a feeling of warmth or tingling, slight swelling in the face or hands, shortness of breath or wheezing, while the acute symptoms can involve anaphylactic shock, mainly severe difficulty in breathing, rapid or irregular heartbeat, and significant drops in blood pressure. The JFDA advised people, who suffered these symptoms after receiving an iron infusion, should immediately seek medical attention at the nearest hospital or emergency center. Source: Jordan News Agency
Home » JFDA Advises Medical Supervision for Iron infusions to Avoid Health Risks
JFDA Advises Medical Supervision for Iron infusions to Avoid Health Risks
Recent post's
Eight Militants Killed in Security Operation in Khyber Pakhtunkhwa
September 24, 2026
GCC Condemns Houthi Missile Launches Toward Saudi Cities of Taif, Yanbu
September 24, 2026
GCC and ASEAN Strengthen Ties at Joint Ministerial Meeting
September 24, 2026
Qatar Engages in Key UN Mediation Meeting
September 24, 2026
Qatar Partners with Memorial Sloan Kettering to Boost Cancer Care
September 24, 2026
GCC and Portugal Forge Agreement to Enhance Bilateral Relations
September 24, 2026
Qatar Engages in Arab Interior Ministers Council Coordination Meeting
September 24, 2026
Sultan bin Saad Al Muraikhi Meets with European Commissioner Magnus Brunner
September 24, 2026